{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:48:18Z","timestamp":1787028498469,"version":"build-2736575974"},"reference-count":32,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Philanthropic-private","award":["nil"],"award-info":[{"award-number":["nil"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Redox imbalance or oxidative stress that results from both environmental and genetic factors is observed in patients with schizophrenia. Therefore, identifying markers of oxidative stress in the early stages of psychosis and using antioxidant treatments as an adjuvant to antipsychotics has important implications. The reaction of p-N,N-dimethylaminobenzaldehyde (DMAB) with pyrrole moieties has been well studied for well over a century for use as a marker of oxidative stress dysregulation. Throughout this time, pyrroles have been investigated with varying veracity in urine extracts to identify elevated levels in patients diagnosed with schizophrenia. Since the 1960\u2019s, various claims have been made with respect to what causes the colour change when DMAB is added to urine extracts. Whilst the substances from this reaction have not been fully elucidated, an objective look at most studies indicates that urobilinogen is likely to be one them. Urobilinogen has also been identified as a major interferent in our results. Both pyrroles and urobilinogen condense the DMAB reaction system (form condensation products) and are quite different. The urobilinogen detected in urine forms when gut microflora chemically reduces the bilirubin content of bile acids. In comparison, evidence suggests that the pyrrole fraction originates from the fragmentation of regulatory haem by reactive oxygen species (ROS) such as hydrogen peroxide and super and nitrous oxides. Clinical studies in our laboratories have established that pyrroles as a urine biomarker have specificity in detecting schizophrenia; however, caution must be applied as the readings are subject to interference by other DMAB active compounds that are present, such as urobilinogen. This review highlights the initial chemistry in isolating pyrroles and provides recommendations for standardised laboratory testing to ensure pyrroles are correctly measured and distinguished from other by-products.<\/jats:p>","DOI":"10.3390\/ijms24032712","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T02:52:02Z","timestamp":1675219922000},"page":"2712","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Pyrroles as a Potential Biomarker for Oxidative Stress Disorders"],"prefix":"10.3390","volume":"24","author":[{"given":"Brett","family":"Lambert","sequence":"first","affiliation":[{"name":"Applied Analytical Laboratories, Logandowns Dr, Meadowbrook, QLD 4131, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2084-4986","authenticated-orcid":false,"given":"Annalese","family":"Semmler","sequence":"additional","affiliation":[{"name":"School of Clinical Sciences, Faculty of Health, Queensland University of Technology, Kelvin Grove, QLD 4059, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Beer","sequence":"additional","affiliation":[{"name":"Centre for Genomics and Personalised Health, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Kelvin Grove, QLD 4059, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6645-6164","authenticated-orcid":false,"given":"Joanne","family":"Voisey","sequence":"additional","affiliation":[{"name":"Centre for Genomics and Personalised Health, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Kelvin Grove, QLD 4059, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,1]]},"reference":[{"key":"ref_1","unstructured":"Guest, G.H. (1938). A Study of Pyrroles in Biological Materials McGill University Libraries, McGill University."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/hlca.193201501123","article-title":"The Pine-Splinter Reaction of Furan Compounds","volume":"15","author":"Reichstein","year":"1932","journal-title":"Helv. Chim. Acta"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/andp.18341070502","article-title":"Ueber einige Produkte der Steinkohlendestillation","volume":"107","author":"Runge","year":"1834","journal-title":"Ann. Physik."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1093\/clinchem\/24.11.2069","article-title":"Hydroxy-hemopyrrolenone, not kryptopyrrole, in the urine of schizophrenics and porphyrics","volume":"24","author":"Irvine","year":"1978","journal-title":"Clin. Chem."},{"key":"ref_5","first-page":"175","article-title":"Malvaria, schizophrenia and the HOD test","volume":"2","author":"Hoffer","year":"1966","journal-title":"Int. J. Neuropsychiatr."},{"key":"ref_6","first-page":"331","article-title":"The presence of unidentified substances in the urine of psychiatric patients","volume":"2","author":"Hoffer","year":"1961","journal-title":"J. Neuropsychiatr."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1744-9081-6-41","article-title":"A polymorphism in the dysbindin gene (DTNBP1) associated with multiple psychiatric disorders including schizophrenia","volume":"6","author":"Voisey","year":"2010","journal-title":"Behav. Brain Funct."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.5694\/mja16.00935","article-title":"Physical comorbidities of post-traumatic stress disorder in Australian Vietnam War veterans","volume":"206","author":"McLeay","year":"2017","journal-title":"Med. J. Aust."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1089\/acm.2020.0151","article-title":"Pyroluria: Fact or Fiction?","volume":"27","author":"Warren","year":"2021","journal-title":"J. Altern. Complement. Med."},{"key":"ref_10","first-page":"562","article-title":"The mauve factor: An evaluation","volume":"26","author":"Hughes","year":"1965","journal-title":"Dis. Nerv. Syst."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/2281318a0","article-title":"Mauve factor re-identified as 2,4-dimethyl-3-ethylpyrrole and its sedative effect on the CNS","volume":"228","author":"Sohler","year":"1970","journal-title":"Nature"},{"key":"ref_12","first-page":"292","article-title":"Treatment of Pyroluric Schizophrenia with Large Doses of Pyridoxine and a dietry Supplement of Zinc","volume":"3","author":"Pfeiffer","year":"1974","journal-title":"J. Orthomol. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0031-9384(04)00310-5","article-title":"Reduced violent behavior following biochemical therapy","volume":"82","author":"Walsh","year":"2004","journal-title":"Physiol. Behav."},{"key":"ref_14","first-page":"3","article-title":"The Effectiveness of Targeted Nutrient Therapy in Treatment of Mental Illness","volume":"29","author":"Stuckey","year":"2010","journal-title":"J. Australas. Coll. Nutr. Environ. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1176\/ajp.135.10.1239","article-title":"Pyroluria: A poor marker in chronic schizophrenia","volume":"135","author":"Cruz","year":"1978","journal-title":"Am. J. Psychiatry"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1042\/cs0580469","article-title":"Urine concentration of 3-ethyl-5-hydroxy-4,5-dimethyl-delta 3-pyrrolin-2-one (\u2018mauve factor\u2019) is not causally related to schizophrenia or to acute intermittent porphyria","volume":"58","author":"Gorchein","year":"1980","journal-title":"Clin. Sci. (Lond. Engl. 1979)"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.23937\/2378-3656\/1410027","article-title":"Clinical Test of Pyrroles: Usefulness and Association with Other Biochemical Markers","volume":"2","author":"Mikirova","year":"2015","journal-title":"Clin. Med. Rev. Case Rep."},{"key":"ref_18","first-page":"48","article-title":"Biomarker Case-Detection and Prediction with Potential for Functional Psychosis Screening: Development and Validation of a Model Related to Biochemistry, Sensory Neural Timing and End Organ Performance","volume":"7","author":"Strobel","year":"2016","journal-title":"Front. Psychiatry"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Gonzalez-Liencres, C., Tas, C., Brown, E.C., Erdin, S., Onur, E., Cubukcoglu, Z., Aydemir, O., Esen-Danaci, A., and Br\u00fcne, M. (2014). Oxidative stress in schizophrenia: A case-control study on the effects on social cognition and neurocognition. BMC Psychiatry, 14.","DOI":"10.1186\/s12888-014-0268-x"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1038\/s41380-022-01779-1","article-title":"Gene set enrichment analysis of pathophysiological pathways highlights oxidative stress in psychosis","volume":"27","author":"Pistis","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Rambaud, V., Marzo, A., and Chaumette, B. (2022). Oxidative Stress and Emergence of Psychosis. Antioxidants, 11.","DOI":"10.3390\/antiox11101870"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1089\/cap.2016.0199","article-title":"Micronutrient Therapy for Violent and Aggressive Male Youth: An Open-Label Trial","volume":"27","author":"Hambly","year":"2017","journal-title":"J. Child. Adolesc. Psychopharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.eurpsy.2009.11.011","article-title":"Analysis of HapMap tag-SNPs in dysbindin (DTNBP1) reveals evidence of consistent association with schizophrenia","volume":"25","author":"Voisey","year":"2010","journal-title":"Eur. Psychiatry"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e339","DOI":"10.1038\/tp.2013.111","article-title":"Genome-wide DNA methylation analysis of human brain tissue from schizophrenia patients","volume":"4","author":"Wockner","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e680","DOI":"10.1038\/tp.2015.177","article-title":"Brain-specific epigenetic markers of schizophrenia","volume":"5","author":"Wockner","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"ref_26","first-page":"101","article-title":"p-Dimethylamino benzaldehyde as a Reagent for Organic Drugs","volume":"66","year":"1929","journal-title":"Pharm. Weekbl."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/00004647-200204000-00011","article-title":"Oxidation of bilirubin produces compounds that cause prolonged vasospasm of rat cerebral vessels: A contributor to subarachnoid hemorrhage-induced vasospasm","volume":"22","author":"Clark","year":"2002","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/sj.jcbfm.9600280","article-title":"Bilirubin oxidation products (BOXes) and their role in cerebral vasospasm after subarachnoid hemorrhage","volume":"26","author":"Clark","year":"2006","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e001220","DOI":"10.1161\/JAHA.114.001220","article-title":"Impact of heme and heme degradation products on vascular diameter in mouse visual cortex","volume":"3","author":"Joerk","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"ref_30","first-page":"40","article-title":"Discerning the Mauve Factor, Part 1","volume":"14","author":"McGinnis","year":"2008","journal-title":"Altern. Ther. Health Med."},{"key":"ref_31","first-page":"56","article-title":"Discerning the Mauve factor, Part 2","volume":"14","author":"McGinnis","year":"2008","journal-title":"Altern. Health Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.12740\/PP\/67507","article-title":"Elevated hydroxylactam of hemopyrrole level in urine in perpetrators of extremely violent acts diagnosed with psychosis","volume":"51","author":"Heitzman","year":"2017","journal-title":"Psychiatr. Pol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/2712\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:20:23Z","timestamp":1760120423000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/2712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["ijms24032712"],"URL":"https:\/\/doi.org\/10.3390\/ijms24032712","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,1]]}}}